+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Irritable Bowel Syndrome Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

  • PDF Icon

    Report

  • 116 Pages
  • December 2023
  • Region: Global
  • Acute Market Reports
  • ID: 5921748
Description Jump to:
The 'irritable bowel syndrome (IBS) treatment market' is expected to grow at a CAGR of 10.5% during the forecast period of 2023 to 2031. IBS treatment plays a vital role in providing relief to individuals suffering from IBS, a gastrointestinal disorder characterized by abdominal pain, bloating, and changes in bowel habits. As of 2022, the market exhibited steady growth, driven by increased awareness of IBS and the demand for effective treatments. The IBS market is poised for continued growth, driven by growing awareness of IBS, advancements in treatment options, and the rising prevalence of the condition. Treatment limitations remain a restraint. Key players are expected to maintain their competitive edge through innovation and patient-focused strategies, with revenues projected to rise from 2022 to 2031. Looking ahead to the period from 2023 to 2031, the market is expected to continue evolving with new treatment options and geographic expansion.

Growing Awareness of IBS

In 2022, the Irritable Bowel Syndrome Treatment Market witnessed significant growth due to the increasing awareness of IBS among the general population. More individuals are recognizing the symptoms and seeking diagnosis and treatment. This growing awareness led to higher demand for IBS treatments, making awareness a crucial driver. This trend is expected to continue as a key driver from 2023 to 2031.

Advancements in IBS Treatment

The market was also driven by advancements in IBS treatment options. New medications and therapies, both prescription and over-the-counter, have been introduced to provide relief from IBS symptoms. These treatments offer a range of options for individuals, improving their quality of life. As advancements in treatment continue, they are expected to drive market growth with a high CAGR during the forecast period.

Rising Prevalence of IBS

Another significant driver was the rising prevalence of IBS. The condition affects a substantial portion of the global population, making it a common gastrointestinal disorder. With IBS being a chronic condition, individuals require ongoing treatment, contributing to the market's growth. As the prevalence of IBS continues to rise, it is expected to drive demand for treatment options from 2023 to 2031.

Restraint in the Irritable Bowel Syndrome Treatment Market

Despite its growth, the Irritable Bowel Syndrome Treatment Market faces a restraint related to treatment limitations. In 2022, treatments for IBS focused on symptom management, rather than addressing the root cause of the condition. The absence of a definitive cure acted as a restraint. It is expected that this treatment limitation will continue to be a challenge from 2023 to 2031, necessitating ongoing research efforts to develop more effective treatments.

Market Segmentation by Type: IBS-D treatments Dominate the Market

The Irritable Bowel Syndrome Treatment Market can be segmented by type into IBS-C (Constipation-predominant) and IBS-D (Diarrhea-predominant). In 2022, the highest revenue was attributed to IBS-D treatments, given the high prevalence of this IBS subtype. However, during the forecast period from 2023 to 2031, IBS-C treatments are expected to exhibit the highest CAGR, indicating the need for more effective treatment options for this subtype.

Market Segmentation by Product: Linzess/Constella Dominate the Market

Another crucial segmentation factor is the product category of IBS treatments, which can be divided into Xifaxan, Linzess/Constella, Viberzi, Amitiza, and others. In 2022, the highest revenue came from Linzess/Constella, which are known for their effectiveness in symptom management. However, during the forecast period from 2023 to 2031, Xifaxan is expected to exhibit the highest CAGR, as it offers a targeted approach in addressing IBS symptoms and gaining popularity among patients.

North America Remains the Global Leader

Geographically, the Irritable Bowel Syndrome Treatment Market exhibits diverse trends. North America recorded the highest revenue percentage in 2022, driven by a well-established healthcare system and high awareness of IBS. However, the Asia-Pacific region is expected to have the highest CAGR from 2023 to 2031, as awareness and access to IBS treatments grow in emerging markets.

Market Competition to Intensify during the Forecast Period

The Irritable Bowel Syndrome Treatment Market is characterized by competition among key players, such as Allergan, Takeda Pharmaceutical Company, AbbVie., Takeda Pharmaceutical Company Limited, Pfizer, Inc., Abbott Laboratories, Novartis AG, AstraZeneca PLC, Ironwood Pharmaceuticals Inc., Bausch Health Companies Inc., GlaxoSmithKline, Plc., Lexicon Pharmaceuticals, Inc. and Sucampo Pharmaceuticals, Inc. These companies have consistently invested in research and development to improve IBS treatments and expand their market presence. In 2022, they recorded substantial revenues, and it is expected that their strategic investments will continue to yield high returns from 2023 to 2031. Key strategies include introducing new treatment options, improving patient support, and expanding distribution networks to reach more individuals in need of IBS treatment.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. Key data points that enable the estimation of the Irritable Bowel Syndrome Treatment market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value
  • Geographical revenues generated by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Irritable Bowel Syndrome Treatment market and their expected impact during the forecast period
The market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

  • Type
  • IBS-C
  • Linzess/Constella
  • Amitiza
  • Others
  • IBS-D
  • Xifaxan
  • Viberzi
  • Others
  • Product
  • Xifaxan
  • Linzess/Constella
  • Viberzi
  • Amitiza
  • Others

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Irritable Bowel Syndrome Treatment market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Irritable Bowel Syndrome Treatment market?
  • Which is the largest regional market for Irritable Bowel Syndrome Treatment market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Irritable Bowel Syndrome Treatment market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Irritable Bowel Syndrome Treatment market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Irritable Bowel Syndrome Treatment Market
2.2. Global Irritable Bowel Syndrome Treatment Market, By Type, 2022 (US$ Million)
2.3. Global Irritable Bowel Syndrome Treatment Market, By Product, 2022 (US$ Million)
2.4. Global Irritable Bowel Syndrome Treatment Market, By Geography, 2022 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2022
3. Irritable Bowel Syndrome Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Irritable Bowel Syndrome Treatment Market Vendors
3.2. Strategies Adopted by Irritable Bowel Syndrome Treatment Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031
4. Irritable Bowel Syndrome Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Irritable Bowel Syndrome Treatment Market Value, 2021-2031, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat of Substitutes
4.6.4. Threat of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
5. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
5.3.1. IBS-C
5.3.1.1. Linzess/Constella
5.3.1.2. Amitiza
5.3.1.3. Others
5.3.2. IBS-D
5.3.2.1. Xifaxan
5.3.2.2. Viberzi
5.3.2.3. Others
6. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
6.3.1. Xifaxan
6.3.2. Linzess/Constella
6.3.3. Viberzi
6.3.4. Amitiza
6.3.5. Others
7. North America Irritable Bowel Syndrome Treatment Market, 2021-2031, USD (Million)
7.1. Market Overview
7.2. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
7.3. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
7.4. Irritable Bowel Syndrome Treatment Market: By Region, 2021-2031, USD (Million)
7.4.1. North America
7.4.1.1. U.S.
7.4.1.1.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
7.4.1.1.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
7.4.1.2.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
7.4.1.3.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
8. UK and European Union Irritable Bowel Syndrome Treatment Market, 2021-2031, USD (Million)
8.1. Market Overview
8.2. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
8.3. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
8.4. Irritable Bowel Syndrome Treatment Market: By Region, 2021-2031, USD (Million)
8.4.1. UK and European Union
8.4.1.1. UK
8.4.1.1.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
8.4.1.1.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
8.4.1.2.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
8.4.1.3.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
8.4.1.4.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
8.4.1.5. France
8.4.1.5.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
8.4.1.5.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
8.4.1.6.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
9. Asia Pacific Irritable Bowel Syndrome Treatment Market, 2021-2031, USD (Million)
9.1. Market Overview
9.2. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
9.3. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
9.4. Irritable Bowel Syndrome Treatment Market: By Region, 2021-2031, USD (Million)
9.4.1. Asia Pacific
9.4.1.1. China
9.4.1.1.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
9.4.1.1.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
9.4.1.2.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
9.4.1.3. India
9.4.1.3.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
9.4.1.3.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
9.4.1.4.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
9.4.1.5.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
9.4.1.6.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
10. Latin America Irritable Bowel Syndrome Treatment Market, 2021-2031, USD (Million)
10.1. Market Overview
10.2. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
10.3. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
10.4. Irritable Bowel Syndrome Treatment Market: By Region, 2021-2031, USD (Million)
10.4.1. Latin America
10.4.1.1. Brazil
10.4.1.1.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
10.4.1.1.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
10.4.1.2.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
10.4.1.3.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
11. Middle East and Africa Irritable Bowel Syndrome Treatment Market, 2021-2031, USD (Million)
11.1. Market Overview
11.2. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
11.3. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
11.4. Irritable Bowel Syndrome Treatment Market: By Region, 2021-2031, USD (Million)
11.4.1. Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
11.4.1.1.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
11.4.1.2.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
11.4.1.3.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
12. Company Profile
12.1. Allergan
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Takeda Pharmaceutical Company
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. AbbVie.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Takeda Pharmaceutical Company Limited
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Pfizer, Inc.
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Abbott Laboratories
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Novartis AG
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. AstraZeneca PLC
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Ironwood Pharmaceuticals Inc.
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Bausch Health Companies Inc.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. GlaxoSmithKline, Plc.
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives
12.12. Lexicon Pharmaceuticals, Inc.
12.12.1. Company Overview
12.12.2. Financial Performance
12.12.3. Product Portfolio
12.12.4. Strategic Initiatives
12.13. Sucampo Pharmaceuticals, Inc.
12.13.1. Company Overview
12.13.2. Financial Performance
12.13.3. Product Portfolio
12.13.4. Strategic Initiatives
12.14. Other Notable Players
12.14.1. Company Overview
12.14.2. Financial Performance
12.14.3. Product Portfolio
12.14.4. Strategic Initiatives
List of Figures
Figure 1 Global Irritable Bowel Syndrome Treatment Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Irritable Bowel Syndrome Treatment Market: Quality Assurance
Figure 5 Global Irritable Bowel Syndrome Treatment Market, By Type, 2022
Figure 6 Global Irritable Bowel Syndrome Treatment Market, By Product, 2022
Figure 7 Global Irritable Bowel Syndrome Treatment Market, By Geography, 2022
Figure 8 Market Geographical Opportunity Matrix - Global Irritable Bowel Syndrome Treatment Market, 2022
Figure 9 Market Positioning of Key Irritable Bowel Syndrome Treatment Market Players, 2022
Figure 10 Global Irritable Bowel Syndrome Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
Figure 11 Global Irritable Bowel Syndrome Treatment Market, By Type, 2022 Vs 2031, %
Figure 12 Global Irritable Bowel Syndrome Treatment Market, By Product, 2022 Vs 2031, %
Figure 13 U.S. Irritable Bowel Syndrome Treatment Market (US$ Million), 2021-2031
Figure 14 Canada Irritable Bowel Syndrome Treatment Market (US$ Million), 2021-2031
Figure 15 Rest of North America Irritable Bowel Syndrome Treatment Market (US$ Million), 2021-2031
Figure 16 UK Irritable Bowel Syndrome Treatment Market (US$ Million), 2021-2031
Figure 17 Germany Irritable Bowel Syndrome Treatment Market (US$ Million), 2021-2031
Figure 18 Spain Irritable Bowel Syndrome Treatment Market (US$ Million), 2021-2031
Figure 19 Italy Irritable Bowel Syndrome Treatment Market (US$ Million), 2021-2031
Figure 20 France Irritable Bowel Syndrome Treatment Market (US$ Million), 2021-2031
Figure 21 Rest of Europe Irritable Bowel Syndrome Treatment Market (US$ Million), 2021-2031
Figure 22 China Irritable Bowel Syndrome Treatment Market (US$ Million), 2021-2031
Figure 23 Japan Irritable Bowel Syndrome Treatment Market (US$ Million), 2021-2031
Figure 24 India Irritable Bowel Syndrome Treatment Market (US$ Million), 2021-2031
Figure 25 Australia Irritable Bowel Syndrome Treatment Market (US$ Million), 2021-2031
Figure 26 South Korea Irritable Bowel Syndrome Treatment Market (US$ Million), 2021-2031
Figure 27 Rest of Asia Irritable Bowel Syndrome Treatment Market (US$ Million), 2021-2031
Figure 28 Brazil Irritable Bowel Syndrome Treatment Market (US$ Million), 2021-2031
Figure 29 Mexico Irritable Bowel Syndrome Treatment Market (US$ Million), 2021-2031
Figure 30 Rest of Latin America Irritable Bowel Syndrome Treatment Market (US$ Million), 2021-2031
Figure 31 GCC Irritable Bowel Syndrome Treatment Market (US$ Million), 2021-2031
Figure 32 Africa Irritable Bowel Syndrome Treatment Market (US$ Million), 2021-2031
Figure 33 Rest of Middle East and Africa Irritable Bowel Syndrome Treatment Market (US$ Million), 2021-2031
List of Tables
Table 1 Global Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
Table 2 Global Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)
Table 3 Global Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)
Table 4 Global Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)
Table 5 North America Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
Table 6 North America Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)
Table 7 North America Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)
Table 8 North America Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)
Table 9 U.S. Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
Table 10 U.S. Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)
Table 11 U.S. Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)
Table 12 U.S. Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)
Table 13 Canada Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
Table 14 Canada Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)
Table 15 Canada Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)
Table 16 Canada Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)
Table 17 Rest of North America Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
Table 18 Rest of North America Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)
Table 19 Rest of North America Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)
Table 20 Rest of North America Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)
Table 21 UK and European Union Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
Table 22 UK and European Union Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)
Table 23 UK and European Union Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)
Table 24 UK and European Union Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)
Table 25 UK Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
Table 26 UK Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)
Table 27 UK Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)
Table 28 UK Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)
Table 29 Germany Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
Table 30 Germany Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)
Table 31 Germany Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)
Table 32 Germany Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)
Table 33 Spain Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
Table 34 Spain Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)
Table 35 Spain Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)
Table 36 Spain Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)
Table 37 Italy Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
Table 38 Italy Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)
Table 39 Italy Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)
Table 40 Italy Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)
Table 41 France Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
Table 42 France Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)
Table 43 France Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)
Table 44 France Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)
Table 45 Rest of Europe Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
Table 46 Rest of Europe Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)
Table 47 Rest of Europe Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)
Table 48 Rest of Europe Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)
Table 49 Asia Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
Table 50 Asia Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)
Table 51 Asia Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)
Table 52 Asia Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)
Table 53 China Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
Table 54 China Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)
Table 55 China Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)
Table 56 China Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)
Table 57 Japan Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
Table 58 Japan Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)
Table 59 Japan Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)
Table 60 Japan Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)
Table 61 India Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
Table 62 India Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)
Table 63 India Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)
Table 64 India Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)
Table 65 Australia Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
Table 66 Australia Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)
Table 67 Australia Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)
Table 68 Australia Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)
Table 69 South Korea Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
Table 70 South Korea Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)
Table 71 South Korea Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)
Table 72 South Korea Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)
Table 73 Latin America Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
Table 74 Latin America Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)
Table 75 Latin America Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)
Table 76 Latin America Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)
Table 77 Brazil Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
Table 78 Brazil Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)
Table 79 Brazil Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)
Table 80 Brazil Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)
Table 81 Mexico Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
Table 82 Mexico Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)
Table 83 Mexico Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)
Table 84 Mexico Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)
Table 85 Rest of Latin America Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
Table 86 Rest of Latin America Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)
Table 87 Rest of Latin America Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)
Table 88 Rest of Latin America Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)
Table 89 Middle East and Africa Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
Table 90 Middle East and Africa Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)
Table 91 Middle East and Africa Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)
Table 92 Middle East and Africa Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)
Table 93 GCC Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
Table 94 GCC Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)
Table 95 GCC Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)
Table 96 GCC Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)
Table 97 Africa Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
Table 98 Africa Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)
Table 99 Africa Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)
Table 100 Africa Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)
Table 101 Rest of Middle East and Africa Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
Table 102 Rest of Middle East and Africa Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)
Table 103 Rest of Middle East and Africa Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)
Table 104 Rest of Middle East and Africa Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

Companies Mentioned

  • Allergan
  • Takeda Pharmaceutical Company
  • AbbVie.
  • Takeda Pharmaceutical Company Limited
  • Pfizer, Inc.
  • Abbott Laboratories
  • Novartis AG
  • AstraZeneca PLC
  • Ironwood Pharmaceuticals Inc.
  • Bausch Health Companies Inc.
  • GlaxoSmithKline, Plc.
  • Lexicon Pharmaceuticals, Inc.
  • Sucampo Pharmaceuticals, Inc.

Related Topics

Related Reports

Irritable Bowel Syndrome Treatment Market Size, Share & Analysis Report by Type (IBS-C, IBS-D), Product (Xifaxan, Linzess/Constella, Viberzi, Amitiza), Distribution Channel, Region, and Segment Forecasts, 2025-2030 - Product Image

Irritable Bowel Syndrome Treatment Market Size, Share & Analysis Report by Type (IBS-C, IBS-D), Product (Xifaxan, Linzess/Constella, Viberzi, Amitiza), Distribution Channel, Region, and Segment Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Irritable Bowel Syndrome (IBS) Therapeutics - Global Strategic Business Report - Product Image

Irritable Bowel Syndrome (IBS) Therapeutics - Global Strategic Business Report

  • Report
  • 269 Pages
  • Global
From
Irritable Bowel Syndrome Treatment Market by Type, by Product, by Distribution Channel, and by Region - Product Image

Irritable Bowel Syndrome Treatment Market by Type, by Product, by Distribution Channel, and by Region

  • Report
  • 200 Pages
  • Global
From
Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2024 - Product Image

Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Irritable Bowel Syndrome Treatment Market Report by Type, Product, Distribution Channel, and Region 2024-2032 - Product Image

Irritable Bowel Syndrome Treatment Market Report by Type, Product, Distribution Channel, and Region 2024-2032

  • Report
  • 143 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.